Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome

Nature

Volumn 389, Issue 6653, 1997, Pages 809-815

  Sun, Fang Lin ^a,b   Dean, Wendy L ^a   Kelsey, Gavin ^a   Allen, Nicholas D ^a   Reik, Wolf ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BECKWITH WIEDEMANN SYNDROME; CONTROLLED STUDY; GENE OVEREXPRESSION; GENOME IMPRINTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSACTIVATION; TRANSGENE;

ANIMALS; ANIMALS, NEWBORN; BECKWITH-WIEDEMANN SYNDROME; CELL LINE; CHIMERA; DISEASE MODELS, ANIMAL; DNA METHYLATION; EMBRYONIC AND FETAL DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOMIC IMPRINTING; HUMANS; INSULIN-LIKE GROWTH FACTOR II; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; PHENOTYPE; REPRESSOR PROTEINS; STEM CELLS; TRANS-ACTIVATION (GENETICS);

EID: 0030735169     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/39797     Document Type: Article

References (44)

1. De Chiara, T. M., Efstratiadis, A. & Robertson, E. J. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor-II gene disrupted by targeting. Nature 345, 78-80 (1990).
2. DeChiara, T. M., Robertson, E. J. & Efstratiadis, A. Parental imprinting of the mouse insulin-like growth factor-II gene. Cell 64, 849-859 (1991).
3. Reik, W. & Maher, E. R. Imprinting in clusters: lessons from Beckwith-Wiedemann syndrome. Trends Genet. 13, 330-334 (1997).
4. Leighton, R A., Saam, J. R., Ingram, R. S., Stewart, C. L. & Tilghman, S. M. An enhancer deletion affects both H19 and IGF2 expression. Genes Dev. 9, 2079-2089 (1995).
5. Leighton, P. A., Ingram, R. S., Eggenschwiler, J., Efstratiadis, A. & Tilghman, S. M. Disruption of imprinting caused by deletion of the H19 region in mice. Nature 375, 34-39 (1995).
6. Ripoche, M. A., Kress, C., Pirier, F. & Dandolo, L. Deletion of the H19 transcription unit reveals the existence of a putative imprinting control element. Genes. Dev. 11, 1596-1604 (1997).
7. Sasaki, H. et al. Parental imprinting-potentially active chromatin of the repressed maternal allele of the mouse insulin-like growth factor-II (IGF2) gene. Genes Dev. 6, 1843-1856 (1992).
8. Feil, R., Walter, J., Allen, N. D. & Reik, W. Development control of allelic methylation in the imprinted mouse IGF2 and H19 genes. Development 120, 2933-2943 (1994).
9. Walter, J. et al. in Epigenetic Mechanisms of Gene Regulation (eds Russo, V. E. A., Martienssen, R. A. & Riggs, A. D.) 195-213 (Cold Spring Harbor Laboratory Press, NY, 1996).
10. Ward, A. et al. Genomic regions regulating imprinting and insulin-like growth factor-II promoter 3 activity in transgenics: novel enhancer and silencer elements. Genes Funct. 1, 25-36 (1997).
11. Feinberg, A. P. Genomic imprinting and gene activation in cancer Nature Genet 4, 110-113 (1993).
12. Bates, P. et al. Mammary-cancer in transgenic mice expressing insulin-like growth-factor II (IGFII). Brit. J. Cancer 72, 1189-1193 (1995).
13. Christofori, G., Naik, P. & Hanahan, D. A. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 369, 414-418 (1994).
14. Rogler, C. E. et al. Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor II transgenic mice. J. Biol. Chem. 269, 13779-13784 (1994).
15. Elliott, M. & Maher, E. R. Beckwith-Wiedemann syndrome. J. Med. Genet. 31, 560-564 (1994).
16. Weksberg, R., Shen, D. R., Fei, Y. L., Song, Q. L. & Squire, J. Disruption of insulin-like growth factor-II imprinting in Beckwith-Weidemann syndrome. Nature Genet. 5, 143-150 (1994).
17. Joyce, J. A. et al. Imprinting of Igf2 and H19: Lack of reciprocity in sporadic Beckwith-Wiedemann syndrome. Hum. Mol. Genet. 6, 1543-1548 (1997).
18. Reik, W. et al. Imprinting mutations in the Beckwith-Wiedemann syndrome suggested by an altered imprinting pattern in the IGF2-H19 domain. Hum. Mol. Genet. 4, 2379-2385 (1995).
19. Brown, K. W. et al. Imprinting mutation in the Beckwith-Wiedemann syndrome leads to biallelic IGF2 expression through an H19-independent pathway. Hum. Mol. Genet. 5, 2027-2032 (1996).
20. Lee, M. P., Hu, R. J., Johnson, L. A. & Feinberg, A. P. Human KvLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements. Nature Genet. 15, 181-185 (1997).
21. Kip2 is mutated in Beckwith-Wiedemann syndrome. Nature Genet. 14, 171-173 (1996).
22. Kip2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387, 151-158 (1997).
23. Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev. 11, 973-983 (1997).
24. Lau, M. M. H. et al. Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev. 8, 2953-2963 (1994).
25. Wang, Z. Q., Fun, M. R., Barlow, D. P. & Wagner, E. F. Regulation of embryonic growth and lysosomal targeting by the imprinted IGF2/MPR gene. Nature 372, 464-467 (1994).
26. Ludwig, T. et al. Mouse mutants lacking the type-2 IGF receptor (IGF2R) are rescued from perinatal lethality in IGF2 and IGF1R null backgrounds. Dev. Biol. 177, 517-535 (1996).
27. Ferguson-Smith, A. C., Cattanach, B. M., Barton, S. C., Beechey, C. V. & Surani, M. A. Embryological and molecular investigations of parental imprinting on mouse chromosome 7. Nature 351, 667-670 (1991).
28. Lee, J. E., Trantrahavi, U., Boyle, A. L. & Efstratiadis, A. Parental imprinting of an IGF2 transgene. Mol. Reprod. Dev. 35, 382-390 (1993).
29. Hedborg, F., Holmgren, L., Sandstedt, B. & Ohlsson, R. The cell-type specific IGF2 expression during early human development correlates to the pattern of overgrowth and neoplasia in the Beckwith-Wiedemann syndrome. Am. J. Pathol. 145, 802-817 (1994).
30. Schneid, H. et al. Parental allele-specific methylation of the human insulin-like growth factor II gene and Beckwith-Wiedemann syndrome. J. Med. Genet. 30, 353-362 (1993).
31. Slatter, R. E. et al. Mosaic uniparental disomy in Beckwith-Wiedemann syndrome. J. Med. Genet. 31, 749-753 (1994).
32. Morison, I. M., Becroft, D. M., Taniguchi, T., Woods, C. G. & Reeve, A. E. Somatic overgrowth associated with overexpression of insulin-like growth factor II. Nature Med. 2, 311-316 (1996).
33. Pilia, G. et al. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nature Genet. 12, 241-247 (1996).
34. McLaughlin, K. J., Szabo, P., Haegel, H. & Mann, J. R. Mouse embryos with paternal duplication of an imprinted chromosome 7 region die at midgestation and lack placental spongiotrophoblast. Development 122, 265-270 (1996).
35. Shemer, R. et al. Dynamic methylation adjustment and counting as part of imprinting mechanisms. Proc. Natl Acad. Sci. USA 93, 6371-6376 (1996).
36. Hatada, I. et al. Aberrant methylation of an imprinted gene U2af1-rs1 caused by its own transgene. J. Biol. Chem. 272, 9120-9122 (1997).
37. Lee, J. T. & Jaenisch, R. Long-range cis effects of ectopic X-inactivation centres on a mouse autosome. Nature 386, 272-275 (1997).
38. Herzing, L. B. K., Romer, J. T., Horn, J. M. & Ashworth, A. Xist has properties of the X-chromosome inactivation centre. Nature 386, 272-275 (1997).
39. Sasaki, H. et al. Nucleotide sequence of a 28 kb mouse genomic region comprising the imprinted Igf2 gene. DNA Res. 3, 331-335 (1996).
40. Rotwein, P. & Hall, L. J. Evolution of insulin-like growth factor II: characterisation of the mouse Igf2 gene and identification of two pseudo-exons. DNA Cell Biol. 9, 725-735 (1990).
41. Sambrook, J., Fritsch, E. F. & Maniatis, T. Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press, NY, 1989).
42. Robertson, E. J. in Teratocarcinomas and Embryonic Stem Cells: A Practical Approach (ed. Robertson, E. J.) 71-112 (IRL, Oxford, 1987).
43. Melton, D. A. et al. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 12, 7035-7056 (1984).
44. Ward, A. & Elliss, C. in The Insulin-like Growth Factors: Structure and Biological Functions (ed. Schofield, P.) 45-70 (Oxford Univ. Press, 1992).